Health ❯ Healthcare

Vaccine Development

Clinical Trials mRNA Technology mRNA Vaccines Regulatory Approval Operation Warp Speed Moderna Vaccine Safety Vaccine Efficacy COVID-19 Vaccines Vaccine Recommendations

3 ARTICLES

last mo.

FDA Advisers Review Moderna’s mRNA Flu Shot mFlusiva

The agency’s choice will shape access for older adults by setting post‑authorization tests to fill evidence gaps on very frail and immunocompromised people.

8 ARTICLES

2mo ago

FDA Advisers Recommend XFG as Target for 2026–2027 COVID-19 Vaccines

11 ARTICLES

3mo ago

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

3 ARTICLES

4mo ago

CDC Vaccine Advisers Pause Push to End mRNA COVID Shot Recommendations

3 ARTICLES

5mo ago

WHO Sets 2026 Flu Vaccine Strains for Northern Hemisphere After H3N2 Variant Gains Ground

5 ARTICLES

5mo ago

India Launches Indigenous Td Vaccine at CRI Kasauli

16 ARTICLES

5mo ago

Stanford’s Nasal Vaccine Shows Broad, Months-Long Protection in Mice as Team Prepares Human Trials

6 ARTICLES

6mo ago

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

6 ARTICLES

6mo ago

Lancet Commission Calls for Publicly Led, Citizen-Centred Universal Health Care in India

7 ARTICLES

6mo ago

Huge Turnout Crowds Galicia Hospitals as RSV Vaccine Trial Opens to All Adults

8 ARTICLES

6mo ago

Brazil Launches Pilot Single-Dose Dengue Vaccination in Three Cities

3 ARTICLES

7mo ago

Biofabri, Bharat Biotech Sign MTBVAC Tech-Transfer Deal to Scale TB Vaccine Supply

3 ARTICLES

7mo ago

T Cell Receptor Switches From Closed to Open in Native Membrane, Rewriting Activation Model

16 ARTICLES

7mo ago

FDA Reportedly Weighing Black Box Warning for COVID-19 Vaccines

5 ARTICLES

8mo ago

Russia's Flu Cases Climb With H3N2 Dominant as Early Tests Back Vaccine Fit

14 ARTICLES

8mo ago

Early H3N2 Surge Triggers EU Vaccine Push as mRNA Flu Shots Outperform in Phase 3

4 ARTICLES

8mo ago

Moderna Secures $1.5 Billion Loan, Outlines Path to 2028 Breakeven

6 ARTICLES

8mo ago

Biovac Opens Cape Town Product Development Lab to Advance Africa’s Vaccine Capacity

6 ARTICLES

8mo ago

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

3 ARTICLES

9mo ago

CDC Backs Broad Fall COVID Vaccination as Pharmacies and States Safeguard Access

Vaccine Development

FDA Advisers Review Moderna’s mRNA Flu Shot mFlusiva

FDA Advisers Recommend XFG as Target for 2026–2027 COVID-19 Vaccines

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

CDC Vaccine Advisers Pause Push to End mRNA COVID Shot Recommendations

WHO Sets 2026 Flu Vaccine Strains for Northern Hemisphere After H3N2 Variant Gains Ground

India Launches Indigenous Td Vaccine at CRI Kasauli

Stanford’s Nasal Vaccine Shows Broad, Months-Long Protection in Mice as Team Prepares Human Trials

Moderna, Merck Melanoma Vaccine Shows Durable Five-Year Benefit as Stock Hits 52-Week High

Lancet Commission Calls for Publicly Led, Citizen-Centred Universal Health Care in India

Huge Turnout Crowds Galicia Hospitals as RSV Vaccine Trial Opens to All Adults

Never miss stories about

Vaccine Development

Brazil Launches Pilot Single-Dose Dengue Vaccination in Three Cities

Biofabri, Bharat Biotech Sign MTBVAC Tech-Transfer Deal to Scale TB Vaccine Supply

T Cell Receptor Switches From Closed to Open in Native Membrane, Rewriting Activation Model

FDA Reportedly Weighing Black Box Warning for COVID-19 Vaccines

Russia's Flu Cases Climb With H3N2 Dominant as Early Tests Back Vaccine Fit

Early H3N2 Surge Triggers EU Vaccine Push as mRNA Flu Shots Outperform in Phase 3

Moderna Secures $1.5 Billion Loan, Outlines Path to 2028 Breakeven

Biovac Opens Cape Town Product Development Lab to Advance Africa’s Vaccine Capacity

Moderna Trims 2025 Forecast as Q3 Loss Narrows and Revenue Beats

CDC Backs Broad Fall COVID Vaccination as Pharmacies and States Safeguard Access

Never miss stories about

Vaccine Development